Nov 5, 2018

Transplantation of human pluripotent stem cells overexpressing insulin/ERRγ can efficiently decrease the HbA1c levels of type 2 diabetes patient (Case #2-A)

BioRxiv : the Preprint Server for Biology
Taihua WangGang Zhang


This paper has been withdrawn by bioRxiv following a screening error that led to its posting in breach of our policy of not posting case reports.

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Glycated Hemoglobin TEST
Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Hemoglobin, Glycosylated
Pluripotent Stem Cells
Regular Insulin, Human
Metabolic Pathway
Blood Glucose Measurement
Screening Generic

About this Paper

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

Canadian Family Physician Médecin De Famille Canadien
Scientific American
Mark Fischetti
Biophysical Journal
Leslie M Loew
© 2020 Meta ULC. All rights reserved